Cali, Colombia, C/Can 2025 aprendizaje clave : desafío de ciudades contra el cáncer
Abstract
Cali (Colombia) will be the first city in the world to implement the initiative “C/Can 2025: City Cancer Challenge”1 (http://www.uicc.org/what-we-do/convening/ccan-2025-city-cancer-challenge). With 2.4 million inhabitants, Cali is the second-largest city of Colombia and a key urban focal point for the immigration of the country’s rural population which represents one fifth of Colombia’s 45.5 million inhabitants.
Authors
Downloads
Keywords
- Cancer
- c/can 2025
- Cali
- Colombia
- Union for International Cancer Control
References
Adams C, Henshall S, Torode J, D’Cruz AK, Kumar HS, Aranda S. C/Can 2025: City Cancer Challenge, a new initiative to improve cancer care in cities. Lancet Oncol. 2017; 18(3): 286-7.
C/Can 2025 City Cancer Challenge. Guiding Principles for Quality Cancer Treatment Services in Cities. Geneva: Union for International Cancer Control; 2017.
Aguilera LJ, Murcia MEM. Servicios Oncológicos de Colombia. Boletín de Servicios Oncológicos, Instituto Nacional de Cancerología. 2016. Available from: http://www.cancer.gov.co/files/libros/archivos/%20Servicios%20Oncologicos%20Bolet%C3%ADn.pdf.
Bravo LE, Collazos T, Collazos P, García LS, Correa P. Trends of cancer incidence and mortality in Cali, Colombia. 50 years experience. Colomb Med (Cali). 2012; 43(4): 246-55.
Bravo LE, García LS, Collazos P, Aristizabal P, Ramirez O. Descriptive epidemiology of childhood cancer in Cali: Colombia 1977-2011. Colomb Med (Cali). 2013; 44(3): 155-64.
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015; 385(9972): 977-1010.
Ospina-Romero M, Portilla CA, Bravo LE, Ramirez O, VIGICANCER working group . Caregivers’ self-reported absence of social support networks is related to treatment abandonment in children with cancer. Pediatr Blood Cancer. 2016; 63: 825-31.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
